Pure Biologics Spólka Akcyjna Capital Reinvestment Ratio
Pure Biologics Spólka Akcyjna capital reinvestment ratio. Pure Biologics Spólka Akcyjna (PUR) has a Capital Reinvestment Ratio of 0.04x as of March 2024, meaning it reinvests 0% of its operating cash flow (zł2.04 Million) in capital expenditures (zł85.00K). Check PUR cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Pure Biologics Spólka Akcyjna (2019–2019)
Capital reinvestment ratio of Pure Biologics Spólka Akcyjna from 2019 to 2019. This chart tracks Pure Biologics Spólka Akcyjna's Capital Reinvestment Ratio across 1 annual periods. Also explore PUR year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Pure Biologics Spólka Akcyjna Capital Reinvestment Ratio by Year (2019–2019)
Pure Biologics Spólka Akcyjna capital reinvestment ratio by year from 2019 to 2019. For the full cash flow conversion analysis, see Pure Biologics Spólka Akcyjna cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (PLN) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2019 | 0.03x | zł5.33 Million | zł161.92K | — |